Valuation Abbott Laboratories Buenos Aires S.E.
Stocks
ABT
ARDEUT110608
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Buenos Aires S.E.
2026-11-02
|
5-day change | 1st Jan Change | ||
| 45,620.00 ARS | +3.68% |
|
+3.92% | -4.52% |
Company Valuation: Abbott Laboratories
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 241,365 | 191,427 | 191,088 | 196,184 | 217,859 | 190,619 | - | - |
| Change | - | -20.69% | -0.18% | 2.67% | 11.05% | -12.5% | - | - |
| Enterprise Value (EV) 1 | 249,166 | 198,318 | 198,871 | 202,693 | 222,266 | 214,174 | 210,758 | 207,036 |
| Change | - | -20.41% | 0.28% | 1.92% | 9.66% | -3.64% | -1.6% | -1.77% |
| P/E | 35.7x | 28.1x | 33.8x | 14.8x | 33.7x | 36.4x | 26.5x | 22.5x |
| PBR | 6.93x | 5.2x | 4.94x | 4.11x | 4.18x | 4.02x | 3.97x | 3.79x |
| PEG | - | -36.9x | -2x | 0x | -0.7x | -1.9x | 0.7x | 1.2x |
| Capitalization / Revenue | 5.6x | 4.39x | 4.76x | 4.68x | 4.91x | 3.82x | 3.56x | 3.35x |
| EV / Revenue | 5.78x | 4.54x | 4.96x | 4.83x | 5.01x | 4.29x | 3.94x | 3.64x |
| EV / EBITDA | 19.4x | 15.9x | 19.5x | 19.1x | 18.9x | 16.1x | 14.6x | 13.4x |
| EV / EBIT | 22x | 17.7x | 22.3x | 21.8x | 21.6x | 18.4x | 16.6x | 15x |
| EV / FCF | 28.8x | 25.4x | 39.3x | 31.9x | 30.1x | 26.2x | 23.2x | 21.5x |
| FCF Yield | 3.47% | 3.94% | 2.54% | 3.13% | 3.33% | 3.82% | 4.3% | 4.66% |
| Dividend per Share 2 | 1.82 | 1.92 | 2.08 | 2.24 | 2.4 | 2.594 | 2.765 | 2.941 |
| Rate of return | 1.29% | 1.75% | 1.89% | 1.98% | 1.92% | 2.35% | 2.51% | 2.67% |
| EPS 2 | 3.94 | 3.91 | 3.26 | 7.64 | 3.72 | 3.023 | 4.155 | 4.904 |
| Distribution rate | 46.2% | 49.1% | 63.8% | 29.3% | 64.5% | 85.8% | 66.6% | 60% |
| Net sales 1 | 43,075 | 43,653 | 40,109 | 41,950 | 44,328 | 49,964 | 53,528 | 56,931 |
| EBITDA 1 | 12,815 | 12,485 | 10,188 | 10,635 | 11,735 | 13,300 | 14,424 | 15,492 |
| EBIT 1 | 11,324 | 11,231 | 8,911 | 9,295 | 10,301 | 11,663 | 12,715 | 13,827 |
| Net income 1 | 7,071 | 6,933 | 5,723 | 13,402 | 6,524 | 5,643 | 7,663 | 8,535 |
| Net Debt 1 | 7,801 | 6,891 | 7,783 | 6,509 | 4,407 | 23,555 | 20,139 | 16,417 |
| Reference price 2 | 140.74 | 109.79 | 110.07 | 113.11 | 125.29 | 110.16 | 110.16 | 110.16 |
| Nbr of stocks (in thousands) | 1,714,968 | 1,743,574 | 1,736,059 | 1,734,455 | 1,738,834 | 1,730,383 | - | - |
| Announcement Date | 1/26/22 | 1/25/23 | 1/24/24 | 1/22/25 | 1/22/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 36.44x | 4.29x | 16.1x | 2.35% | 191B | |
| 21.35x | 3.66x | 13.1x | 2.86% | 122B | |
| 26.33x | 4.72x | 16.13x | 1.18% | 117B | |
| 32.8x | 3.15x | 12.71x | 2.17% | 96.21B | |
| 17.92x | 0.21x | 13.38x | 0.7% | 64.47B | |
| 29.83x | 7.43x | 18.98x | 1.36% | 52.51B | |
| 40.48x | 3.63x | 12.36x | 2.1% | 54.1B | |
| 44.66x | 11.28x | 31.6x | -.--% | 52.91B | |
| 43.69x | 3.46x | 12.85x | 0.5% | 35.65B | |
| Average | 32.61x | 4.65x | 16.36x | 1.47% | 87.2B | |
| Weighted average by Cap. | 31.35x | 4.38x | 15.83x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
- Valuation Abbott Laboratories
Select your edition
All financial news and data tailored to specific country editions
